Scherma M - Search Results

1

Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse.

Solinas M, Scherma M, Fattore L, Stroik J, Wertheim C, Tanda G, Fratta W, Goldberg SR. Solinas M, et al. Among authors: scherma m. J Neurosci. 2007 May 23;27(21):5615-20. doi: 10.1523/JNEUROSCI.0027-07.2007. J Neurosci. 2007. PMID: 17522306 Free PMC article.

2

An overall view of the most common experimental models for multiple sclerosis.

Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, Frau J, Cocco E, Fadda P. Dedoni S, et al. Among authors: scherma m. Neurobiol Dis. 2023 Aug;184:106230. doi: 10.1016/j.nbd.2023.106230. Epub 2023 Jul 13. Neurobiol Dis. 2023. PMID: 37453561 Free article. Review.

3

Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring.

Santoni M, Sagheddu C, Serra V, Mostallino R, Castelli MP, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Santoni M, et al. Among authors: scherma m. Brain Behav Immun. 2023 Mar;109:271-284. doi: 10.1016/j.bbi.2023.02.002. Epub 2023 Feb 4. Brain Behav Immun. 2023. PMID: 36746342 Free article.

4

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.

Fadda P, Scherma M, Fresu A, Collu M, Fratta W. Fadda P, et al. Among authors: scherma m. Synapse. 2003 Oct;50(1):1-6. doi: 10.1002/syn.10238. Synapse. 2003. PMID: 12872287

5

Cannabinoids and reward: interactions with the opioid system.

Fattore L, Cossu G, Spano MS, Deiana S, Fadda P, Scherma M, Fratta W. Fattore L, et al. Among authors: scherma m. Crit Rev Neurobiol. 2004;16(1-2):147-58. doi: 10.1615/critrevneurobiol.v16.i12.160. Crit Rev Neurobiol. 2004. PMID: 15581410 Review.

6

Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice.

Fadda P, Scherma M, Fresu A, Collu M, Fratta W. Fadda P, et al. Among authors: scherma m. Synapse. 2005 Apr;56(1):29-38. doi: 10.1002/syn.20122. Synapse. 2005. PMID: 15700287

7

Endocannabinoid system and opioid addiction: behavioural aspects.

Fattore L, Deiana S, Spano SM, Cossu G, Fadda P, Scherma M, Fratta W. Fattore L, et al. Among authors: scherma m. Pharmacol Biochem Behav. 2005 Jun;81(2):343-59. doi: 10.1016/j.pbb.2005.01.031. Pharmacol Biochem Behav. 2005. PMID: 15935459 Review.

8

Cannabinoid self-administration increases dopamine release in the nucleus accumbens.

Fadda P, Scherma M, Spano MS, Salis P, Melis V, Fattore L, Fratta W. Fadda P, et al. Among authors: scherma m. Neuroreport. 2006 Oct 23;17(15):1629-32. doi: 10.1097/01.wnr.0000236853.40221.8e. Neuroreport. 2006. PMID: 17001282

9

Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.

Solinas M, Scherma M, Tanda G, Wertheim CE, Fratta W, Goldberg SR. Solinas M, et al. Among authors: scherma m. J Pharmacol Exp Ther. 2007 Jun;321(3):1127-34. doi: 10.1124/jpet.106.116830. Epub 2007 Mar 9. J Pharmacol Exp Ther. 2007. PMID: 17351107

10

The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.

Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR. Scherma M, et al. Neuropharmacology. 2008 Jan;54(1):129-40. doi: 10.1016/j.neuropharm.2007.08.011. Epub 2007 Aug 19. Neuropharmacology. 2008. PMID: 17904589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters